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The worldwide spread of COVID-19 is especially causing a humanitarian
catastrophe in refugee camps in crisis regions.1 For example, currently
over 350 000 survivors of Islamic State of Iraq and Syria (ISIS) terrorism
in the Kurdistan region of Iraq live in more than 20 refugee camps. These
communities, which had already been traumatized, are now confronted
with further adversities that exacerbate the ongoing psychological suffer-
ing and lead to increased suicide rates2; however, medical and psychologi-
cal care is limited,3 and the work of humanitarian actors is restricted.4
Moreover, social distancing is almost impossible in high-density camps,
and hygiene practices are often simply not applicable.5 The objective of
our pilot study was to briefly examine for the very first time the develop-
ment of mental health of a cohort of Yazidis in a refugee camp in Iraq
using selective psychometric measures before and shortly after the
COVID-19 outbreak.
The participants were aged between 18 and 58 years (N = 68; mean
age = 45.72 years, SD = 3.52 years; 38 females). They had fled from ISIS
in 2014 and have since been living in a refugee camp near the city of
Duhok, Iraq. This cohort was interviewed in October 2019 prior to the
COVID-19 pandemic and, having adapted the study to challenging cir-
cumstances, again in April 2020 during the spread of COVID-19 through
demographic questionnaires, the revised Impact of Event Scale (IES-R),6
and the Composite International Diagnostic Interview (CIDI).7 Descrip-
tive data are illustrated as the mean values of the standard deviation, and
categorical parameters are presented as percentages. The presented com-
parison of both investigated groups was calculated with χ2-tests, t-tests,
and a univariate two-factor analysis of variance. Questionnaires in
Kurdish were read by native Kurdish interviewers who had been trained
by the research team at the Institute for Psychotherapy and Psycho-
traumatology at the University of Duhok under the leadership of the first
author of this correspondence. The investigation was approved by the
University Review Board of the University of Duhok; all subjects gave
informed consent.
The refugees had not been taken captive but had friends or family
members who had been murdered. They lived in small tents together with
8–12 other people and their educational level ranged from 0 to 12 years
of school attendance (mean = 6.8 years, SD = 2.61 years). Approximately
88% of the respondents were victims of a terror attack, 34% had
witnessed a person being beaten or tortured, and 69% had lost at least
one sibling. The mean initial IES-R total score for females was 9.2/15
(SD = 2.6, Mdn = 11, range = 10–15) and that for males was 6.2/15
(SD = 2.4, Mdn = 10, range = 10–15). Yazidi who had individually expe-
rienced rape or torture were excluded from this investigation because they
evidenced markedly high post-traumatic stress disorder (PTSD) rates and
comorbidities even before the COVID-19 pandemic.8 The different psy-
chometric prevalence rates of mental disorders in October 2019 and April
2020 according to CIDI were calculated and then sex-matched compared
(Table 1).
The prevalence of PTSD increased to ~58% (95% confidence inter-
val [CI] = 34.1%–62.5%) in females and ~47% (95% CI = 28.5%–
52.4%) in males (Table 1); its rate was significantly higher among women
than among men (~43% vs ~58%), χ2(1, N = 68) = 9.2, P < 0.01. In
2019, the women had reported an average of 9.04 (SD = 2.82) of the
17 DSM-IV PTSD symptoms compared to an average of 4.76
(SD = 2.04) symptoms for the men, F(1, 137) = 7.8, P < 0.01. In 2020,
women reported an average of 12.01 (SD = 3.12) of the DSM-IV symp-
toms compared to 6.46 (SD = 2.16) symptoms reported by men, F
(1, 327) = 9.1, P < 0.01.
The results of the IES-R for men and women together show a signif-
icant effect in the PTSD subdomains comprising ‘reexperiencing the
event,’ ‘avoidance and numbness of feelings,’ ‘hyperarousal,’ and ‘reper-
cussions of the preceding symptoms on activities of daily living.’ The
reexperiencing values (IES-R; range = 0–35) result in a mean of 32.4
(SD = 4.68); on the Avoidance subscale (range 0–40), a mean value of
Table 1. Sex-matched (male vs female) prevalence rates of mental disorders in October 2019 (before COVID-19) and April 2020 (during
COVID-19) according to the Composite International Diagnostic Interview
Mental disorder
2019 (before COVID-19) 2020 (during COVID-19)
Male (%) n = 30 Female (%) n = 38 Male (%) n = 30 Female (%) n = 38
Depression 36.7 (11) 42.1 (16) 43.3 (13) 47.4 (18)
Anxiety 46.7 (14) 52.6 (20) 56.7 (16) 63.2 (24)
Somatoform 33.3 (10) 42.1 (16) 36.7 (11) 44.7 (17)
Dissociation 0 (0) 26.3 (10) 0 (0) 31.6 (12)
Post-traumatic stress disorder 36.7 (11) 47.4 (18) 43.3 (13) 57.9 (22)
Reexperiencing the event 36.7 (11) 47.4 (18) 43.3 (13) 57.9 (22)
Avoidance of reminders of the event and numbness of
feelings
36.7 (11) 42.1 (16) 43.3 (13) 63.2 (24)
Hyperarousal 36.7 (11) 47.4 (18) 43.3 (13) 57.9 (22)
Repercussions of the preceding symptoms on activities
of daily living
36.7 (11) 42.1 (16) 43.3 (13) 44.7 (17)
Suicidal ideas 26.7 (8) 42.1 (16) 30.0 (9) 47.4 (17)
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36.5 (SD = 4.81) is achieved; and on the Hyperarousal subscale
(range = 0–35), a mean value of 30.1 (SD = 5.14) is achieved. The docu-
mented differences are highly statistically significant (P < 0.001) and can
be described as ‘severe’ in all patients.
During the COVID-19 pandemic, the probability of PTSD and other
mental disorders in refugees, especially women, increased in comparison
with the already difficult situation before the crisis.
The complete isolation and the impossibility of leaving the refugee
camp probably reactivated the traumatic experience with a feeling of help-
lessness, similar to that during captivity or flight.
Altogether, our analyses in a refugee camp provide additional evi-
dence that being unable to obtain any medical support, the experience of
repeated helplessness, and the loss of control seem to play an impressive
role among those who still report suffering from traumatization and other
mental disorders 5 years after experiencing genocide.
The limitations of the current study in refugees living in camps –
the first of its kind during the COVID-19 pandemic – include the use of a
cross-sectional cohort and in the first instance a relatively small sample
size with a limited set of psychometric instruments.
Future studies are required to investigate the impact of the current
pandemic on refugees with existing psychological problems. The develop-
ment of adapted mental treatment approaches for refugees during future
pandemics seems wise and urgently necessary.
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The COVID-19 pandemic has led to a significant elevation of psychologi-
cal distress in the general population, with reports of moderate to severe
increases in anxiety, depression, and stress.1 Obsessive–compulsive disor-
der (OCD) patients might be especially vulnerable to increased psycho-
logical distress,2–4 as many aspects of the COVID-19 crisis focus on
uncertainty and cleanliness, which are core symptoms of many OCD
patients.3 Alternatively, individuals with OCD tend to direct their attention
toward their inner mental thoughts5 and thus might be less affected by
external events. Similarly, OCD symptoms tend to be specific and subjec-
tive5 and thus the existence of a new virus would not necessarily increase
the fear of contamination. Furthermore, quarantine may instead lead to
patients feeling more protected from harm or that their concerns sur-
rounding cleanliness or preventing harm are ‘justified,’ which might con-
sequently provide them with some relief. Therefore, we assessed OCD
symptom change in response to COVID-19 during the period of quaran-
tine in Israel.
Sixty-five participants who reported being diagnosed with OCD by a
licensed psychiatrist completed an online survey consisting of the Depres-
sion Anxiety Stress Scale – 21 (DASS-21)6 and questions regarding their
OCD. This study was approved by the Ethics Committee of the Faculty
of Social Sciences of the Hebrew University of Jerusalem and was com-
pleted between 29 March and 20 April 2020, during a period of mandated
quarantine in Israel, which began on 17 March and ended on 19 April.
The period of mandated quarantine was accompanied by strict guidelines
allowing individuals to leave their residence only for buying food, medi-
cal treatment, and essential work. Participants indicated whether they
experienced symptoms relating to five common categories of OCD symp-
toms: contamination, moral concern, harm avoidance, concerns about
symmetry and exactness, and checking.7, 8 For each endorsed category,
participants reported the duration of their OCD, rated the severity of their
symptoms, and indicated the degree of change in their symptoms in the
past 2 weeks (on a scale from 1 [Significantly worsened] to 5 [Significantly
improved]).
Results indicated that participants were evenly distributed in
reporting improvement (n = 21), worsening (n = 21), or no change
(n = 23) in symptom severity. Of those reporting change, over 70%
reported mild change (16 improved, 14 worsened) and less than 30%
reported a significant change (5 improved, 7 worsened). There were no
differences in symptom severity nor in symptom categories among the
people reporting improved, worsened, or no change in symptom severity
over the past 2 weeks (Fig. 1). Univariate analyses of variance indicated
that compared to participants reporting improvement or no change in
symptom severity, participants reporting worsening of symptoms in the
past 2 weeks reported higher anxiety (DASS-21-A), F(2, 62) = 115.52,
P < 0.001, ηp2 = 0.79, and stress (DASS-21-S), F(2, 62) = 34.49,
P < 0.001, ηp2 = 0.53, but not depression (DASS-21-D), F(2, 62) = 0.21,
P = 0.81. There were no differences across participants who reported
improved, worsened, or no change in symptom severity in age, proportion
of men and women, mean symptom severity, mean onset of earliest symp-
tom, medication status, or psychotherapy status (Fig. 1). A binary logistic
regression analysis was carried out to predict reports of (at least one)
symptom worsening over the past 2 weeks. Type of symptom, current
symptom severity, medication status, psychotherapy status, symptom
onset, sex, age, and DASS subscales were entered as predictors. Results
indicated that only the DASS-21-A and the DASS-21-S were significant
predictors (βDASS-A = 34.164, P < 0.001; βDASS-S = 21.338, P < 0.001).
Similar results were obtained for a binary logistic regression analysis to
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